This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Fraud, S.
Right arrow Articles by Poole, K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Fraud, S.
Right arrow Articles by Poole, K.

 Previous Article  |  Next Article 

Antimicrobial Agents and Chemotherapy, December 2008, p. 4478-4482, Vol. 52, No. 12
0066-4804/08/$08.00+0     doi:10.1128/AAC.01072-08
Copyright © 2008, American Society for Microbiology. All Rights Reserved.

MexCD-OprJ Multidrug Efflux System of Pseudomonas aeruginosa: Involvement in Chlorhexidine Resistance and Induction by Membrane-Damaging Agents Dependent upon the AlgU Stress Response Sigma Factor{triangledown}

Sebastien Fraud,{dagger} Aaron J. Campigotto,{dagger} Zhilin Chen, and Keith Poole*

Department of Microbiology and Immunology, Queen's University, Kingston, Ontario, Canada K7L 3N6

Received 8 August 2008/ Returned for modification 7 September 2008/ Accepted 27 September 2008


arrow
ABSTRACT
 
The biocide chlorhexidine (CHX) as well as additional membrane-active agents were shown to induce expression of the mexCD-oprJ multidrug efflux operon, dependent upon the AlgU stress response sigma factor. Hyperexpression of this efflux system in nfxB mutants was also substantially AlgU dependent. CHX resistance correlated with efflux gene expression in various mutants, consistent with MexCD-OprJ being a determinant of CHX resistance.


arrow
TEXT
 
Pseudomonas aeruginosa is an opportunistic human pathogen characterized by an innate resistance to multiple antimicrobials (13), resistance increasingly attributable to the operation of broadly specific, tripartite multidrug efflux systems of the resistance-nodulation-division (RND) family (35, 36). One of these, MexCD-OprJ, was originally identified as a determinant of fluoroquinolone resistance (17) but is known to accommodate a variety of clinically relevant antimicrobials (35, 36) as well as biocides (5), dyes, detergents, and organic solvents (27, 45, 46). MexCD-OprJ is typically quiescent in wild-type cells (20, 46), with expression following mutation of the nfxB gene (16, 22, 23, 50) that is divergently transcribed from the mexCD-oprJ operon and encodes a repressor of mexCD-oprJ expression (37). Little is known about the signal(s) to which this regulator responds in naturally promoting efflux gene expression, although mexCD-oprJ is inducible by the biocides benzalkonium chloride and chlorhexidine (CHX) (33). These biocides are known to interact with and disrupt bacterial membranes (8), with the possibility that mexCD-oprJ expression is a response to membrane damage/envelope stress. Envelope stress responses (ESRs) are well documented in bacteria (40, 41), with the extracytoplasmic sigma factor RpoE being a key regulator of ESRs in Escherichia coli and other gram-negative bacteria (1, 40, 41). The RpoE homologue in P. aeruginosa is AlgU, first identified as a regulator of alginate production in mucoid isolates recovered from the lungs of cystic fibrosis patients (15, 28) and shown to be functionally interchangeable with RpoE (51). This study was undertaken to assess the contribution of MexCD-OprJ to biocide resistance in P. aeruginosa and its possible regulation as part of an ESR.

Bacterial strains and plasmids used in this study are listed in Table 1. Bacteria were cultivated at 37°C in Luria broth (LB) (34) supplemented with antibiotics to maintain plasmids as needed (for pEX18Tc and derivatives, tetracycline was used [10 µg/ml for E. coli and 50 to 100 µg/ml for P. aeruginosa]; for pMMB206 and derivatives, chloramphenicol was used [10 µg/ml for E. coli and 150 µg/ml for P. aeruginosa]; for pK18MobSacB and derivatives, kanamycin was used [50 µg/ml for E. coli and 750 to 1,500 µg/ml for P. aeruginosa as indicated]; for miniCTX-lacZ and derivatives, tetracycline was used [10 µg/ml for E. coli and 25 µg/ml for P. aeruginosa]; and for pUC19 and derivatives, ampicillin was used [100 µg/ml for E. coli]). AlgU-encoding plasmid pSF02 was constructed by amplifying the algU gene from the chromosome (isolated as described previously [3]) of P. aeruginosa K767 via PCR using Vent DNA polymerase (NEB) and cloning it into pMMB206 (primers and parameters available upon request). To construct the algU strains of P. aeruginosa, an in-frame deletion of the gene was first engineered in the gene replacement vector pK18MobSacB following amplification and cloning ca. 1-kb portions upstream and downstream of the algU sequences being deleted (primers and parameters available upon request). The resultant vector, pSF01, was mobilized into P. aeruginosa (46), and transconjugants were selected on LB agar containing kanamycin (1,500 µg/ml) and imipenem (0.5 µg/ml). Those harboring a chromosomal deletion of algU were subsequently recovered on sucrose plates (46) and screened for the loss of algU using colony PCR (39). The {Delta}mexB-{Delta}mexXY mutant strain K1542 was constructed by introducing the mexXY deletion of plasmid pCSV05 into {Delta}mexB strain K1523 as described previously (7). A {Delta}mexCD-oprJ derivative of P. aeruginosa K1542 was constructed using plasmid pRSP05 as described previously (46), with initial selection of the vector in strain K1542 made on kanamycin (1,000 µg/ml) and imipenem (0.5 µg/ml). Putative {Delta}mexCD-oprJ mutants were recovered from sucrose plates and screened for the loss of mexCD-oprJ using colony PCR (39). A chromosomal mexC-lacZ transcriptional fusion was generated using a previously described procedure (19). A 700-bp region containing the mexCD-oprJ promoter region (PmexCD-oprJ) was PCR amplified from the chromosome of P. aeruginosa K767 and cloned upstream of the promoterless lacZ gene in plasmid miniCTX-lacZ. The resultant vector, pAJC03, was mobilized (46) into P. aeruginosa strains K1542 and K2897 (K1542 {Delta}algU), and transconjugants carrying chromosomal copies of pAJC03 were selected on tetracycline (25 µg/ml) and imipenem (0.5 µg/ml). The miniCTX plasmid backbone was excised using the pFLP-encoded Flp recombinase as described previously (19), leaving the PmexCD-oprJ -lacZ fusion behind. Control derivatives of K1542 and K2897 harboring a promoterless lacZ gene in the chromosome were generated as described above with promoter-free miniCTX-lacZ. β-Galactosidase assays were performed as described previously (31) on cells cultured overnight in LB, diluted 1:49 in fresh LB, and cultured for a further 2 h prior to a 2-h exposure to various membrane-damaging agents (MDAs). P. aeruginosa strains with reduced susceptibility to CHX were isolated, following serial passage in LB containing increasing concentrations (1 to 50 µg/ml) of the biocide (1-µg/ml increments up to 20 µg/ml; 2-µg/ml increments from 20 to 50 µg/ml). Bacteria were incubated for 24 h at 37°C at a given CHX concentration before being harvested by centrifugation, washed twice in 5 ml phosphate-buffered saline (34), and used to inoculate LB cultures (1/100 dilution) containing the next-highest CHX concentration. Individual colonies were recovered from the cultures with the highest concentrations of CHX permitting growth by streaking onto L agar, and stable CHX-resistant mutants were recovered following passage (10 times) in biocide-free LB. Susceptibility testing (34) and reverse transcriptase PCR (RT-PCR) using RNA isolated from log-phase cells (44) after a 2.5-h exposure to various MDAs was carried out as described above (primers and parameters available upon request). rpsL was used as an internal control in RT-PCR to ensure equal loading of RNA in all lanes.


View this table:
[in this window]
[in a new window]

  		TABLE 1. Bacterial strains used in this study

CHX-induced mexCD-oprJ expression is AlgU dependent. Treatment of wild-type P. aeruginosa with the cationic biocides CHX and benzalkonium chloride has been shown to induce mexCD-oprJ expression (33), a result confirmed here for CHX (Fig. 1, lane 2, cf. lane 1). Additional cationic biocides, including alexidine, poly(hexamethylenebiguanide)hydrochloride (PHMB; Vantocil), and cetrimide were tested and also shown to induce mexCD-oprJ expression (Fig. 1, lanes 3 to 5). These agents interact with and disrupt bacterial membranes (8), suggesting that mexCD-oprJ induction may be a response to membrane damage and not to the agents themselves. In E. coli, membrane disruption with chemical agents (40, 47) or mutation (47) stimulates expression of genes controlled by the RpoE envelope stress sigma factor. AlgU is the P. aeruginosa homologue of RpoE, and so the involvement of AlgU in CHX-promoted mexCD-oprJ expression was assessed by measuring the impact of an algU knockout. As shown in Fig. 2A, elimination of algU obviated CHX-promoted mexCD-oprJ expression in the wild-type strain K767 (compare lanes 3 and 4), and this was reversed by the cloned algU gene (compare lanes 6 and 7), indicating that AlgU mediates CHX-induced mexCD-oprJ expression. mexCD-oprJ hyperexpression in an nfxB mutant (Fig. 3, lane 3, cf. lane 1) was also compromised in the absence of algU (Fig. 3, lane 4, cf. lane 3) and restored with the cloned algU gene (Fig. 3, lane 8, cf. lane 7), consistent with AlgU also being involved in mutational mexCD-oprJ expression.


Figure 1
View larger version (66K):
[in this window]
[in a new window]

  		FIG. 1. Biocide induction of mexCD-oprJ expression in P. aeruginosa. Expression of mexD and rpsL was assessed in wild-type P. aeruginosa PAO1 strain K767 grown in the absence of biocide (lane 1) or after a 2.5-h exposure to a fourth of the MIC of the cationic biocides CHX (2.5 µg/ml) (lane 2), PHMB (1 µg/ml) (lane 2), alexidine (3 µg/m) (lane 2), or cetrimide (100 µg/ml) (lane 2) by semiquantitative RT-PCR. The PCR portion was carried out at 32 (top mexD panel) and 34 (bottom mexD panel) or 20 (top rpsL panel) and 22 (bottom rpsL panel) cycles.


Figure 2
View larger version (42K):
[in this window]
[in a new window]

  		FIG. 2. Impact of CHX and AlgU on mexCD-oprJ expression in P. aeruginosa. Expression of mexD and rpsL was assessed in P. aeruginosa strains K767 (wild type) (lanes 1 and 3), K2443 ({Delta}algU) (lanes 2, 4, and 5), and K2443 carrying pMMB206 (lane 6) or pSF02 (pMMB206::algU) (lane 7) (A) or in strains K1542 ({Delta}mexB {Delta}mexXY) (lanes 1 and 3) and K2897 ({Delta}mexB {Delta}mexXY {Delta}algU) (lanes 2 and 4) grown in the absence of CHX (–CHX) or after a 2.5-h exposure to a quarter of the MIC of this biocide (2.5 µg/ml for AlgU+ strains and 0.33 µg/ml for AlgU– strains) (+CHX) by semiquantitative RT-PCR (B). The PCR portion was carried out at 33 (top mexD panel) and 35 (bottom mexD panel) or 23 (top rpsL panel) and 25 (bottom rpsL panel) cycles.


Figure 3
View larger version (30K):
[in this window]
[in a new window]

  		FIG. 3. Impact of algU on mexCD-oprJ expression in nfxB strain K1536. The expression of mexD and rpsL was assessed in P. aeruginosa strains K767 (lanes 1), K2443 ({Delta}algU) (lane 2), K1536 (nfxB) (lanes 3 and 5), K2895 (nfxB {Delta}algU) (lanes 4 and 6), and K2895 carrying pMMB206 (lane 7) or pSF02 (pMMB206::algU) (lane 8) by semiquantitative RT-PCR. Cycle numbers are as per the legend to Fig. 2.

Additional membrane-active agents induce mexCD-oprJ. If membrane damage is a signal for mexCD-oprJ induction, additional MDAs should promote expression of this efflux operon. To assess this, P. aeruginosa was treated with sub-MIC levels of several agents known to target and disrupt the cytoplasmic and/or outer membranes of this organism, including solvents (ethanol [10, 21, 42], hexane, and xylene [38, 42, 48]), a detergent (sodium dodecyl sulfate [SDS]) (14, 42, 49), EDTA (12, 30), and several cationic antimicrobials (polymyxin B, melittin, and antimicrobial peptides V8 and V681 [9, 11, 24, 52]). A strain lacking the MexAB-OprM and MexXY-OprM efflux systems, K1542, was used in these studies to avoid possible problems with the export of MDAs by these efflux systems, compromising their membrane-damaging activities (solvents and SDS are, for example, known efflux substrates [27, 45]). Initially, CHX inducibility of mexCD-oprJ was assessed in this strain and, as in strain K767, it was seen to be AlgU dependent (Fig. 2B). Using a chromosomal PmexCD-oprJ-lacZ reporter to assess the impact of MDAs on mexCD-oprJ expression subsequently revealed that efflux gene expression was induced by all MDAs tested, though CHX was the most effective inducer (Fig. 4). Although the effects seen were modest (ca. 1.5- to 3-fold), the increased mexCD-oprJ expression revealed by the reporter fusion correlated with increased resistance of MDA-treated K1542 (but not its {Delta}mexCD-oprJ derivative K2896) to MexCD-OprJ substrate antimicrobials (a 2- to 4-fold increase in norfloxacin MICs and a 4- to 16-fold increase in erythromycin MICs [data not shown]). As with CHX-treated K767, the loss of algU compromised MDA induction of mexCD-oprJ in K1542 (Fig. 4) as well as MDA-promoted antibiotic resistance (data not shown). These data are consistent with AlgU and MexCD-OprJ playing a role in the ESR of P. aeruginosa, possibly orchestrating membrane changes necessary for adaptation to MDAs.


Figure 4
View larger version (24K):
[in this window]
[in a new window]

  		FIG. 4. Impact of membrane-active agents on PmexCD-oprJ-lacZ expression in P. aeruginosa. P. aeruginosa K2899 (K1542::PmexCD-oprJ-lacZ) (black bars) and AlgU– derivative K2901 (K2897::PmexCD-oprJ-lacZ) (white bars) were grown to log phase in the presence or absence of CHX, polymyxin B (PXB), ethanol (ETOH), SDS, melittin (MEL), EDTA, n-hexane (HEX), p-xylene (XYL), and the cationic antimicrobial peptides V8 and V681 and assayed for β-galactosidase activity. Values for activity measured were subsequently adjusted for background levels seen for promoter-free, lacZ-containing strains K2900 (K1542::promoterless lacZ) and K2902 (K2897::promoterless lacZ). The results shown are the fold change in activity observed in the presence versus the absence of the indicated agent and are the mean ± the standard deviation of at least two independent experiments performed in triplicate. MDAs were used under the following conditions: CHX, 1/8 MIC (1.25 and 0.16 µg/ml for K2899 and K2901 derivatives, respectively); polymyxin B, 1/4 MIC (0.125 µg/ml); ethanol, 1/8 MIC (0.5% [vol/vol]); SDS, 1/16 MIC (3.1 µg/ml); melittin, 1/4 MIC (15 µg/ml); EDTA, 1/16 MIC (11.6 µg/ml); n-hexane, 1/4 MIC (1.25% [vol/vol]); p-xylene, 1/8 MIC (0.0156% [vol/vol]); antimicrobial peptide V8, 1/8 MIC (8 µg/ml); and antimicrobial peptide V681, 1/8 MIC (16 µg/ml)]. Various MDA concentrations were tested, and results are shown for concentrations that did not adversely impact growth.

Salmonella enterica RpoE, like AlgU, is also linked to membrane damage and resistance to MDAs, as the sigma factor is inducible by cationic antimicrobial peptides and is required for antimicrobial peptide resistance (6). Similarly, carbon source starvation, which apparently causes membrane stress that induces rpoE in this organism, also promotes resistance to polymyxin B that is RpoE dependent (25).

MexCD-OprJ and CHX resistance. Despite the earlier report of CHX induction of mexCD-oprJ, a possible contribution of this efflux system to CHX resistance was not examined (33). Compared to their MexCD-OprJ+ parents K1542 and K767, mutants lacking mexCD-oprJ (K2896 and K1521) were more susceptible to this biocide, while an nfxB mutant hyperexpressing this efflux system, K1536, was more resistant than its parent, K767 (Table 2), consistent with MexCD-OprJ contributing to CHX resistance. Consistent with AlgU's role in the hyperexpression of mexCD-oprJ in an nfxB mutant, the loss of algU in this mutant markedly enhanced CHX susceptibility (Table 2; compare K1536 and K2895). Similarly, {Delta}algU strains K2897 and K2443 were also more susceptible to CHX than their parents K1542 and K767, consistent with AlgU contributing to CHX-promoted mexCD-oprJ expression. In all instances, the increased CHX susceptibility of {Delta}algU strains was reversed by the cloned algU gene (Table 2). Interestingly, {Delta}algU derivatives K2897 and K2443 were more susceptible to CHX than the {Delta}mexCD-oprJ derivatives (K2896 and K1521), and a double mutant lacking both loci (K2898) was more susceptible still (Table 2). These data are consistent with an additional AlgU-regulated gene(s) contributing to CHX resistance. Still, MexCD-OprJ appears to be the most important AlgU-regulated determinant of CHX resistance and, indeed, highly CHX-resistant mutants selected following serial passage of P. aeruginosa in CHX-containing media were recoverable only from a MexCD-OprJ+ strain (Table 2). The presence or absence of mexCD-oprJ or algU did not impact susceptibility to any of the other MDAs examined in this study (data not shown), consistent with the more modest influence of these agents on mexCD-oprJ expression or their being, possibly, poor substrates for this efflux system.


View this table:
[in this window]
[in a new window]

  		TABLE 2. Contribution of AlgU and MexCD-OprJ to CHX resistance in P. aeruginosaa


arrow
ACKNOWLEDGMENTS
 
We thank Bob Hancock for the mexD::mini-Tn5-luxCDABE mutant and the antimicrobial peptides V8 and V681. Ramakrishnan Srikumar is thanked for his construction of the P. aeruginosa strain K1542.

This work was supported by an operating grant from the Canadian Cystic Fibrosis Foundation. A.J.C. is an Ontario Graduate Scholar.


arrow
FOOTNOTES
 
* Corresponding author. Mailing address: Department of Microbiology and Immunology, Queen's University, Kingston, Ontario, Canada K7L 3N6l. Phone: (613) 533-6677. Fax: (613) 533-6796. E-mail: poolek{at}queensu.ca Back

{triangledown} Published ahead of print on 6 October 2008. Back

{dagger} Both authors contributed equally to this work. Back


arrow
REFERENCES
 
    1
  1. Alba, B. M., and C. A. Gross. 2004. Regulation of the Escherichia coli {sigma}E-dependent envelope stress response. Mol. Microbiol. 52:613-619.[CrossRef][Medline]
    2. 2
  2. Ausubel, F. M., R. Brent, R. E. Kingston, D. D. Moore, J. G. Seidman, J. A. Smith, and K. Struhl. 1992. Short protocols in molecular biology, 2nd ed. John Wiley & Sons, Inc., New York, NY.
    3. 3
  3. Barcak, G. J., M. S. Chandler, R. J. Redfield, and J. F. Tomb. 1991. Genetic systems in Haemophilus influenzae. Methods Enzymol. 204:321-342.[Medline]
    4. 4
  4. Becher, A., and H. P. Schweizer. 2000. Integration-proficient Pseudomonas aeruginosa vectors for isolation of single-copy chromosomal lacZ and lux gene fusions. BioTechniques 29:948-950, 952.[Medline]
    5. 5
  5. Chuanchuen, R., K. Beinlich, T. T. Hoang, A. Becher, R. R. Karkhoff-Schweizer, and H. P. Schweizer. 2001. Cross-resistance between triclosan and antibiotics in Pseudomonas aeruginosa is mediated by multidrug efflux pumps: exposure of a susceptible mutant strain to triclosan selects nfxB mutants overexpressing MexCD-OprJ. Antimicrob. Agents Chemother. 45:428-432.[Abstract/Free Full Text]
    6. 6
  6. Crouch, M. L., L. A. Becker, I. S. Bang, H. Tanabe, A. J. Ouellette, and F. C. Fang. 2005. The alternative sigma factor {sigma}E is required for resistance of Salmonella enterica serovar Typhimurium to anti-microbial peptides. Mol. Microbiol. 56:789-799.
    7. 7
  7. De Kievit, T. R., M. D. Parkins, R. J. Gillis, R. Srikumar, H. Ceri, K. Poole, B. H. Iglewski, and D. G. Storey. 2001. Multidrug efflux pumps: expression patterns and contribution to antibiotic resistance in Pseudomonas aeruginosa. Antimicrob. Agents Chemother. 45:1761-1770.[Abstract/Free Full Text]
    8. 8
  8. Gilbert, P., and L. E. Moore. 2005. Cationic antiseptics: diversity of action under a common epithet. J. Appl. Microbiol. 99:703-715.[CrossRef][Medline]
    9. 9
  9. Gilleland, H. E., Jr., F. R. Champlin, and R. S. Conrad. 1984. Chemical alterations in cell envelopes of Pseudomonas aeruginosa upon exposure to polymyxin: a possible mechanism to explain adaptive resistance to polymyxin. Can. J. Microbiol. 30:869-873.[Medline]
    10. 10
  10. Gustafson, C., and C. Tagesson. 1985. Influence of organic solvent mixtures on biological membranes. Br. J. Ind. Med. 42:591-595.[Medline]
    11. 11
  11. Hancock, R. E., and A. Rozek. 2002. Role of membranes in the activities of antimicrobial cationic peptides. FEMS Microbiol. Lett. 206:143-149.[CrossRef][Medline]
    12. 12
  12. Hancock, R. E., and P. G. Wong. 1984. Compounds which increase the permeability of the Pseudomonas aeruginosa outer membrane. Antimicrob. Agents Chemother. 26:48-52.[Abstract/Free Full Text]
    13. 13
  13. Hancock, R. E. W., and D. P. Speert. 2000. Antibiotic resistance in Pseudomonas aeruginosa: mechanisms and impact on treatment. Drug Resist. Update. 3:247-255.[CrossRef][Medline]
    14. 14
  14. Helenius, A., and K. Simons. 1975. Solubilization of membranes by detergents. Biochim. Biophys. Acta 415:29-79.[Medline]
    15. 15
  15. Hershberger, C. D., R. W. Ye, M. R. Parsek, Z. D. Xie, and A. M. Chakrabarty. 1995. The algT (algU) gene of Pseudomonas aeruginosa, a key regulator involved in alginate biosynthesis, encodes an alternative sigma factor ({sigma}E). Proc. Natl. Acad. Sci. USA 92:7941-7945.[Abstract/Free Full Text]
    16. 16
  16. Higgins, P. G., A. C. Fluit, D. Milatovic, J. Verhoef, and F. J. Schmitz. 2003. Mutations in GyrA, ParC, MexR and NfxB in clinical isolates of Pseudomonas aeruginosa. Int. J. Antimicrob. Agents 21:409-413.[CrossRef][Medline]
    17. 17
  17. Hirai, K., S. Suzue, T. Irikura, S. Iyobe, and S. Mitsuhashi. 1987. Mutations producing resistance to norfloxacin in Pseudomonas aeruginosa. Antimicrob. Agents Chemother. 31:582-586.[Abstract/Free Full Text]
    18. 18
  18. Hirakata, Y., R. Srikumar, K. Poole, N. Gotoh, T. Suematsu, S. Kohno, S. Kamihira, R. E. Hancock, and D. P. Speert. 2002. Multidrug efflux systems play an important role in the invasiveness of Pseudomonas aeruginosa. J. Exp. Med. 196:109-118.[Abstract/Free Full Text]
    19. 19
  19. Hoang, T. T., R. R. Karkhoff-Schweizer, A. J. Kutchma, and H. P. Schweizer. 1998. A broad-host-range Flp-FRT recombination system for site-specific excision of chromosomally-located DNA sequences: application for isolation of unmarked Pseudomonas aeruginosa mutants. Gene 212:77-86.[CrossRef][Medline]
    20. 20
  20. Hosaka, M., N. Gotoh, and T. Nishino. 1995. Purification of a 54-kilodalton protein (OprJ) produced in NfxB mutants of Pseudomonas aeruginosa and production of a monoclonal antibody specific to OprJ. Antimicrob. Agents Chemother. 39:1731-1735.[Abstract]
    21. 21
  21. Ingram, L. O. 1976. Adaptation of membrane lipids to alcohols. J. Bacteriol. 125:670-678.[Abstract/Free Full Text]
    22. 22
  22. Jakics, E. B., S. Iyobe, K. Hirai, H. Fukuda, and H. Hashimoto. 1992. Occurrence of the nfxB type mutation in clinical isolates of Pseudomonas aeruginosa. Antimicrob. Agents Chemother. 36:2562-2565.[Abstract/Free Full Text]
    23. 23
  23. Jalal, S., O. Ciofu, N. Hoiby, N. Gotoh, and B. Wretlind. 2000. Molecular mechanisms of fluoroquinolone resistance in Pseudomonas aeruginosa isolates from cystic fibrosis. Antimicrob. Agents Chemother. 44:710-712.[Abstract/Free Full Text]
    24. 24
  24. Katsu, T., M. Kuroko, T. Morikawa, K. Sanchika, Y. Fujita, H. Yamamura, and M. Uda. 1989. Mechanism of membrane damage induced by the amphipathic peptides gramicidin S and melittin. Biochim. Biophys. Acta 983:135-141.[Medline]
    25. 25
  25. Kenyon, W. J., D. G. Sayers, S. Humphreys, M. Roberts, and M. P. Spector. 2002. The starvation-stress response of Salmonella enterica serovar Typhimurium requires {sigma}E, but not CpxR-regulated extracytoplasmic functions. Microbiology 148:113-122.[Abstract/Free Full Text]
    26. 26
  26. Lewenza, S., R. K. Falsafi, G. Winsor, W. J. Gooderham, J. B. McPhee, F. S. Brinkman, and R. E. Hancock. 2005. Construction of a mini-Tn5-luxCDABE mutant library in Pseudomonas aeruginosa PAO1: a tool for identifying differentially regulated genes. Genome Res. 15:583-589.[Abstract/Free Full Text]
    27. 27
  27. Li, X.-Z., L. Zhang, and K. Poole. 1998. Role of the multidrug efflux systems of Pseudomonas aeruginosa in organic solvent tolerance. J. Bacteriol. 180:2987-2991.[Abstract/Free Full Text]
    28. 28
  28. Martin, D. W., B. W. Holloway, and V. Deretic. 1993. Characterization of a locus determining the mucoid status of Pseudomonas aeruginosa: AlgU shows sequence similarities with a Bacillus sigma factor. J. Bacteriol. 175:1153-1164.[Abstract/Free Full Text]
    29. 29
  29. Masuda, N., and S. Ohya. 1992. Cross-resistance to meropenem, cephems, and quinolones in Pseudomonas aeruginosa. Antimicrob. Agents Chemother. 36:1847-1851.[Abstract/Free Full Text]
    30. 30
  30. Matsushita, K., O. Adachi, E. Shinagawa, and M. Ameyama. 1978. Isolation and characterization of outer and inner membranes from Pseudomonas aeruginosa and effect of EDTA on the membranes. J. Biochem. (Tokyo) 83:171-181.[Abstract/Free Full Text]
    31. 31
  31. Miller, J. H. 1992. A short course in bacterial genetics. A laboratory manual and handbook for Escherichia coli and related bacteria, p.72-74. Cold Spring Harbor Laboratory Press, Plainview, NY.
    32. 32
  32. Morales, V. M., A. Backman, and M. Bagdasarian. 1991. A series of wide-host-range low-copy-number vectors that allow direct screening for recombinants. Gene 97:39-47.[CrossRef][Medline]
    33. 33
  33. Morita, Y., T. Murata, T. Mima, S. Shiota, T. Kuroda, T. Mizushima, N. Gotoh, T. Nishino, and T. Tsuchiya. 2003. Induction of mexCD-oprJ operon for a multidrug efflux pump by disinfectants in wild-type Pseudomonas aeruginosa PAO1. J. Antimicrob. Chemother. 51:991-994.[Abstract/Free Full Text]
    34. 34
  34. Nehme, D., X. Z. Li, R. Elliot, and K. Poole. 2004. Assembly of the MexAB-OprM multidrug efflux system of Pseudomonas aeruginosa: identification and characterization of mutations in mexA compromising MexA multimerization and interaction with MexB. J. Bacteriol. 186:2973-2983.[Abstract/Free Full Text]
    35. 35
  35. Poole, K. 2004. Efflux pumps, p. 635-674. In J.-L. Ramos (ed.), Pseudomonas, vol. I: genomics, life style and molecular architecture. Kluwer Academic/Plenum Publishers, New York, NY.
    36. 36
  36. Poole, K. 2005. Efflux-mediated antimicrobial resistance. J. Antimicrob. Chemother. 56:20-51.[Abstract/Free Full Text]
    37. 37
  37. Poole, K., N. Gotoh, H. Tsujimoto, Q. Zhao, A. Wada, T. Yamasaki, S. Neshat, J.-I. Yamagishi, X.-Z. Li, and T. Nishino. 1996. Overexpression of the mexC-mexD-oprJ efflux operon in nfxB multidrug resistant strains of Pseudomonas aeruginosa. Mol. Microbiol. 21:713-724.[CrossRef][Medline]
    38. 38
  38. Ramos, J. L., E. Duque, M. T. Gallegos, P. Godoy, M. I. Ramos-Gonzalez, A. Rojas, W. Teran, and A. Segura. 2002. Mechanisms of solvent tolerance in gram-negative bacteria. Annu. Rev. Microbiol. 56:743-768.[CrossRef][Medline]
    39. 39
  39. Rédly, G. A., and K. Poole. 2003. Pyoverdine-mediated regulation of FpvA synthesis in Pseudomonas aeruginosa: involvement of a probable extracytoplasmic-function sigma factor, FpvI. J. Bacteriol. 185:1261-1265.[Abstract/Free Full Text]
    40. 40
  40. Rowley, G., M. Spector, J. Kormanec, and M. Roberts. 2006. Pushing the envelope: extracytoplasmic stress responses in bacterial pathogens. Nat. Rev. Microbiol. 4:383-394.[CrossRef][Medline]
    41. 41
  41. Ruiz, N., and T. J. Silhavy. 2005. Sensing external stress: watchdogs of the Escherichia coli cell envelope. Curr. Opin. Microbiol. 8:122-126.[Medline]
    42. 42
  42. Sikkema, J., J. A. de Bont, and B. Poolman. 1995. Mechanisms of membrane toxicity of hydrocarbons. Microbiol. Rev. 59:201-222.[Abstract/Free Full Text]
    43. 43
  43. Simon, R., U. Priefer, and A. Puehler. 1983. A broad host range mobilization system for in vivo genetic engineering: transposon mutagenesis in Gram-negative bacteria. Bio Technology 1:784-791.
    44. 44
  44. Sobel, M. L., G. A. McKay, and K. Poole. 2003. Contribution of the MexXY multidrug transporter to aminoglycoside resistance in Pseudomonas aeruginosa clinical isolates. Antimicrob. Agents Chemother. 47:3202-3207.[Abstract/Free Full Text]
    45. 45
  45. Srikumar, R., T. Kon, N. Gotoh, and K. Poole. 1998. Expression of Pseudomonas aeruginosa multidrug efflux pumps MexA-MexB-OprM and MexC-MexD-OprJ in a multidrug-sensitive Escherichia coli strain. Antimicrob. Agents Chemother. 42:65-71.[Abstract/Free Full Text]
    46. 46
  46. Srikumar, R., X.-Z. Li, and K. Poole. 1997. Inner membrane efflux components are responsible for the β-lactam specificity of multidrug efflux pumps in Pseudomonas aeruginosa. J. Bacteriol. 179:7875-7881.[Abstract/Free Full Text]
    47. 47
  47. Tam, C., and D. Missiakas. 2005. Changes in lipopolysaccharide structure induce the {sigma}E-dependent response of Escherichia coli. Mol. Microbiol. 55:1403-1412.
    48. 48
  48. White, S. H., G. I. King, and J. E. Cain. 1981. Location of hexane in lipid bilayers determined by neutron diffraction. Nature (London) 290:161-163.[CrossRef]
    49. 49
  49. Woldringh, C. L., and W. van Iterson. 1972. Effects of treatment with sodium dodecyl sulfate on the ultrastructure of Escherichia coli. J. Bacteriol. 111:801-813.[Abstract/Free Full Text]
    50. 50
  50. Yoshida, T., T. Muratani, S. Iyobe, and S. Mitsuhashi. 1994. Mechanisms of high-level resistance to quinolones in urinary tract isolates of Pseudomonas aeruginosa. Antimicrob. Agents Chemother. 38:1466-1469.[Abstract/Free Full Text]
    51. 51
  51. Yu, H., M. J. Schurr, and V. Deretic. 1995. Functional equivalence of Escherichia coli {sigma}E and Pseudomonas aeruginosa AlgU: E. coli rpoE restores mucoidy and reduces sensitivity to reactive oxygen intermediates in algU mutants of P. aeruginosa. J. Bacteriol. 177:3259-3268.[Abstract/Free Full Text]
    52. 52
  52. Zhang, L., R. Benz, and R. E. Hancock. 1999. Influence of proline residues on the antibacterial and synergistic activities of {alpha}-helical peptides. Biochemistry 38:8102-8111.

Antimicrobial Agents and Chemotherapy, December 2008, p. 4478-4482, Vol. 52, No. 12
0066-4804/08/$08.00+0     doi:10.1128/AAC.01072-08
Copyright © 2008, American Society for Microbiology. All Rights Reserved.



This article has been cited by other articles:

  • Lister, P. D., Wolter, D. J., Hanson, N. D. (2009). Antibacterial-Resistant Pseudomonas aeruginosa: Clinical Impact and Complex Regulation of Chromosomally Encoded Resistance Mechanisms. Clin. Microbiol. Rev. 22: 582-610 [Abstract] [Full Text]  

This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Fraud, S.
Right arrow Articles by Poole, K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Fraud, S.
Right arrow Articles by Poole, K.

Copyright © 2009 by the American Society for Microbiology.   For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»